A team led by Howard Chang has contributed key technology to enable new experimental cancer therapy that uses CRISPR to edit immune cells.
Researchers zeroed in on the genes driving ground squirrel hibernation — and their insights could be helpful for understanding human health.
In his quest to cure his daughter’s ultra-rare disease, Matt Wilsey might also be changing the way drugs are made, Stanford Business magazine reports.
Scientists have used CRISPR-Cas9 screens to reveal more about how the bacteria behind Legionnaire's disease infects humans.
Mammalian cells use a label to distinguish self from non-self circular RNA molecules. Foreign molecules can trigger anti-cancer immune responses.
Scientists at Stanford use a gene therapy technique, called RNA silencing, to treat a heart condition called restrictive cardiomyopathy in mice.
A Stanford scientist and his son harness RNA sequencing to discover the genomic mutation behind the uncommon California poppy.
Stanford scientists have found 16 new genetic variants linked to a greater risk for autism, a finding that could help identify biomarkers for the disorder.
As a freshly minted undergraduate, Kristin Reese had a strange side hustle. With her trusty ice chest, Reese helped collect donor hearts for a research …
Through the Humanwide project, a patient's pharmacogenomic evaluation helped doctors prescribe a pain reliever that is effective for her individual biology.
A Stanford researcher explains that genome-wide association studies of psychiatric disorders are far more reliable than older, smaller genetic studies.
Stanford geneticists discuss the future of genomics, including the importance of studying diverse populations for medical research.
Stanford scientists and collaborators have harnessed CRISPR to replace the mutated gene underpinning the devastating immune disease, SCID-X1.
New research has found that many regions of Mexico lack genetic counselors; increased outreach and training could help, Stanford researcher suggests.
Molecular data identifies breast cancer subgroups likely to recur decades after successful treatment, predicts probable timing and location of metastases.
Scientists at Stanford have developed a tool that helps them track "off-target" gene edits that come as an accidental result of gene editing.